Botanical species · safety record

Wrightia tinctoria

The EFSA Compendium of Botanicals holds 13 constituent measurements for Wrightia tinctoria. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Wrightia tinctoria R.Br.

13Constituent measurements

0Safety records

5Cited sources

5Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 5 licensed products naming Wrightia tinctoria as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Herb top
Leaf
Leaf extract

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Leaves	—	—	Phytochemical screening	No resolvable identifier
Alkaloids	Seed	Solvent extraction	≤ 0.29 Percent	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	No resolvable identifier
Alkaloids	Seed	Solvent extraction	≥ 0.17 Percent	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	No resolvable identifier
Alkaloids	Stem / stalk	—	—	Phytochemical screening	No resolvable identifier
Alkaloids	Bark	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Cardiac glycosides	Live plants	—	—	Phytochemical screening	No resolvable identifier
Saponins	Seed	Solvent extraction	≤ 2.96 Percent	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	No resolvable identifier
Saponins	Roots and other underground parts	—	—	Phytochemical screening	No resolvable identifier
Saponins	Seed	Solvent extraction	≥ 1.96 Percent	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	No resolvable identifier
Tannins	Leaves	—	—	Phytochemical screening	No resolvable identifier
Tannins	Seed	Solvent extraction	—	Gelpermeation, High Performance Thin Layer Chromatography (HPTLC)	No resolvable identifier
Tryptanthrin	Leaves	Solvent extraction	17.21 Percent	Unspecified	No resolvable identifier
Tryptanthrin	Live plants	Solvent extraction	—	—	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Bigoniya, P., Singh, C.S., Shukla, A. Pharmacognostical and physicochemical standardization of ethnopharmacologically important seeds of Lepidium sativum Linn. and Wrightia tinctoria R. Br. Indian journal of natural products and resources, 2011, vol. 2, no. 4, p. 464-471.
Khyade, Mahendra S., Vaikos, Nityanand P. Wrightia tinctoria R. Br.(-)a review on its ethnobotany, pharmacognosy and pharmacological profile . Journal of coastal life medicine, 2014, vol. 2, no. 10, p. 826-840.
Muruganandam, AV., Jaiswal, AK., Ghosal, S., Bhattacharya, SK. Effect of Wrightia tinctoria on the brain monoamines and metabolites in rats . Biogenic amines, 1998, vol. 14, no. 6, p. 655-665.
Muruganandam, AV., Bhattacharya, SK., Ghosal, S. Indole and flavanoid constituents of Wrightia tinctoria, W-tomentosa and W-coccinea . Indian journal of chemistry section b-organic chemistry including medicinal chemistry, 2000, vol. 39, no. 2, p. 125-131.
Sethi, P. D. Separation of alkaloidal constituents of Wrightia tinctoria by TLC [thin-layer chromatography]. Planta Medica, 1969, p. 26-29.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature